Abstract
The syndrome of spasticity still confronts us with several unsolved problems in the theoretical as well as in the clinical field.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angel RW, Hofmann WW (1963) The H reflex in normal, spastic and rigid subjects. Arch Neurol 8:591–596
Andrews PLR, Wood KL (1986) Systemic baclofen stimulates gastric motility and secretion via a central action in the rat. Br J Pharmacol 89:461–467
Aptekar RG, Ford F, Bleck EE (1976) Light patterns as a mean of assessing and recording gait. Part 1: Methods and results in normal children. Dev Med Child Neurol 18:31–36
Aptekar RG, Ford F, Bleck EE (1976) Light patterns as a mean of assessing and recording gait. Part 2: Results in children with cerebral palsy. Dev Med Child Neurol 18:37–40
Aring CD (1973) Pain in multiple sclerosis. J Am Med Assoc 223:547
Ashworth B (1964) Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192:540–542
Ault A, Evans HE (1981) The depressant action of baclofen on the isolated spinal cord of the neonatal rat. Eur J Pharmacol 71:357–364
Ault B, Nadler JV (1983) Anticonvulsant-like actions of baclofen in the rat hippocampal slice. Br J Pharmacol 78:701–708
Awapara J (1950) Detection and identification of metabolites in tissued by means of paper chromatography. Fed Proc 9:148
Badr GG, Matousek M, Frederiksen PK (1983) A quantitative EEG analysis of the effects of baclofen on man. Neuropsycho-biology 10:13–18
Barker I, Grant I (1982) Convulsions after abrupt withdrawal of baclofen. Lancet II:556–557
Basmajian JV (1975) Lioresal treatment of spasticity in multiple sclerosis. Am J Phys Med 54:175–177
Baum E (1981) Motographie 1. Bundesanstalt für Arbeitsschutz, Wirtschaftsverlag
Bayerl JR, Gruia D (1985) Klinische Vergleichsstudie der Antispastika Memantin und Baclofen. Therapiewoche 35:5440–5444
Bazemore AW, Elliott KAC, Florey E (1957) Isolation of factor I. J Neurochem 1:334–339
Ben-Ari J, Henry JL (1976) Effects of the parchlorphenyl derivate of GAB A on spinal neurones in the cat. J Physiol (Lond) 259:469–470
Benecke R, Conrad B, Höhne J, Meinck HM (1983) Quantitative analyses of the effect of antispastic drugs upon locomotor activity. Agressologie 24:147–149
Benecke R, Conrad B, Meinck HM (1984) Neue Erkenntnisse zur Pathophysiologie der Spastizität. In: Conrad B, Benecke R, Bauer HJ (eds) Die klinische Wertung der Spastizität. Schattauer, Stuttgart New York, pp 17–31
Benedito MAC, Leite JR (1981) Baclofen as an anticonvulsant in experimental models of convulsions. Exp Neurol 72:346–351
Bergamini L, Riccio A, Bergamasco B (1966) Un farmaco ad azione antispastica della musculatura striata. Sperimentatione clinica di un derivato del GABA. Minerva Med 57:2723–2725
Birkmayer W (1972) Spasticity — a topical survey. Huber, Wien
Bousquet P, Feldman J, Bloch R, Schwartz J (1981) The central hypotensive action of baclofen in the anaesthetized cat. Eur J Pharmacol 76:193–201
Bowery NG (1982) Baclofen 10 years on. Trends Pharmacol Sci 3:400–403
Bowery NG (1983) Le Baclofene tel qu’il se présente au bout de dix ans. Gaz Med Fr 90:2891–2897
Bowery NG, Hill DR, Hudson AL, Doble A, Middlemiss DN, Shaw J, Turnhull M (1980) (-)Baclofen decreases neurotransmitter release in the mammalian CNS by action at a novel GABA receptor. Nature 283:92–94
Brill B, Greve J (1985) Photographische Bewegungsanalyse bei neurologischen Störungen und ihre Bedeutung für die Rehabilitation. In: Schimrigk K, Haaß A (eds) Zentrale Bewegungsstörungen — Arzneimittelinterferenzen. Perimed, Erlangen, pp 37–54
Brodie BB (1960) The importance of dissociation constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid. J Pharmacol Exp Ther 130:20–25
Burke D, Andrews C, Knowles L (1971) The action of a GABA derivate in human spasticity. J Neurol Sci 14:199–208
Burke D, Gillies DJ, Lance JW (1970) The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry 33:216–223
Capek R, Esplin B (1982) Baclofen-induced decrease of excitability of primary afferents and depression of monosynaptic transmission in cat spinal cord. Can J Physiol Pharmacol 60:160–167
Cartlidge NEF, Hudgson P, Weightman D (1974) A comparison of baclofen and diazepam in the treatment of spasticity. J Neurol Sci 23:17–24
Cendrowski W, Sobczyk W (1977) Clonazepam, baclofen and placebo in the treatment of spasticity. Eur Neurol 16: 257–262
Chahl LA, Walker SB (1980) The effect of baclofen on the cardiovascular system of the rat. Br J Pharmacol 69:631–637
Coletti A, Mandelli A, Minoli G, Tredici EP (1980) Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and gabaergic drugs. J Neurol 223:67–70
Conrad B, Benecke R (1985) Bewegungsanalyse zentralmotorischer Krankheiten als Mittel der Therapiekontrolle. In: Schimrigk K, Haaß A (eds) Zentrale Bewegungsstörungen — Arzneimittelinterferenzen. Perimed, Erlangen, pp 55–63
Conrad B, Benecke R, Meinck HM (1984) Qualitative and quantitative Aspekte der spastischen Bewegungsstörung der unteren Extremität. In: Conrad B, Benecke R, Bauer HJ (eds) Die klinische Wertung der Spastizität. Schattauer, Stuttgart New York, pp 73–84
Corli O, Roma G, Bacchini M, Battagliarin G, Di Piazza D, Brambilla C, Grossi E (1984) Double-blind placebo-controlled trial of baclofen, alone and in combination, in patients undergoing voluntary abortion. Clin Ther 6:800–807
Corston RN, Johnson F, Godwin-Austen RB (1981) The assessment of drug treatment of spastic gait. J Neurol Neurosurg Psychiatry 44:1035–1039
Curtis DR, Game CJA, Johnston GAR, McCulloch RM (1974) Central effects of β-(p-chlorphenyl)-gamma-aminobutyric acid. Brain Res 70:493–500
Curtis DR, Lodge D, Bornstein JC, Peet MJ (1981) Selective effect of (-)baclofen on spinal synaptic transmission in the cat. Exp Brain Res 42:158–170
Curtis DR, Johnston GAR (1974) Amino acid transmitters in the mammalian central nervous system. Ergeb Physiol 69:97–188
Cutting DA, Jordan CC (1975) Alternative approach to analgesia: Baclofen as a model compound. Br J Pharmacol 54:171–176
Davidoff RA (1980) Effects of baclofen on synaptic activity in the spinal cord. In: Feldman RG, Young RR, Koella WP (eds) Spasticity: Disordered motor control. Year Book, Chicago, pp 421–436
Davidoff RA, Sears ES (1974) The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology 24:957–963
Davies J (1981) Selective depression of synaptic excitation in cat spinal neurons by baclofen: an iontophoretic study. Br J Pharmacol 72:373–384
Defeudis FV (1982) Studies on GABA and cardiovascular function using in vivo and in vitro technics. Drug Develop Res 2:507–517
Defeudis FV (1983) Gamma-aminobutyric acid and cardiovascular function. Experientia 39:845–849
Delwaide PJ (1985) Electrophysiological analysis of the mode of action of muscle relaxants in spasticity. Ann Neurol 17:90–95
Delwaide PJ, Cordonnier M (1977) Traitement médicamenteux de la spasticité. Méd Hyg 35:2053–2061
Delwaide PJ, Cordonnier M, Gadea-Ciria M (1978) Excitability relationship between lower limb myotactic arcs in spasticity. J Neurol Neurosurg Psychiatry 41:636–641
Delwaide PJ, Martinelli P, Crenna P (1980) Clinical neurophysiological measurement of spinal reflex activity. In: Feldman RG, Young GG, Koalla WP (eds) Spasticity: disordered motor control. Year Book, Chicago, pp 345–371
Delwaide P, Schoenen J (1984) Auswahl des Antispastikums unter besonderer Berücksichtigung der jeweils vorliegenden Pathophysiologie der Spastizität. In: Conrad B, Benecke R, Bauer HJ (eds) Die klinische Wertung der Spastizität. Schattauer, Stuttgart New York, pp 91–96
Di Chiro G (1966) Observations on the circulation of the cerebrospinal fluid. Acta Radiol [Diagn] (Stockh) 5:988–996
Dickinson AH, Brewer CM, Hayes NA (1985) Effect of topical baclofen on C-fibre-evoked neuronal activity in the rat dorsal horn. Neuroscience 14:557–562
Dimitrijevic MR, Nathan PW (1967) Studies of spasticity in man. 2. Analysis of stretch reflexes in spasticity. Brain 90:333–358
Dimitrijevic MR, Sherwood AM (1980) Spasticity: medical and surgical treatment. Neurology 30:19–27
Drayer BP, Rosenbaum AE (1978) Studies of the third circulation. J Neurosurg 48:946–953
Duncan GW, Shahani BT, Young RR (1976) An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions: a double-blind cross over study. Neurology (Minneapolis) 26:441–446
Dunlap K (1981) Two types of gamma-aminobutyric acid receptors on embryonic sensory neurones. Br J Pharmacol 74:579–585
Enna SJ, Maggi A (1979) Biochemical pharmacology of gabaergic agonists. Life Sci 24:1727–1738
Fehr HU, Bein HJ (1974) Sites of action of a new muscle relaxant (baclofen, Lioresal, CIBA 34 647-Ba). J Int Med Res 2:36–47
Feldman RG, Kelly-Hayes M, Comony JP, Foley JM (1978) Baclofen for spasticity in multiple sclerosis: double-blind crossover and three-year study. Neurology 28:1094–1098
Florey E (1954) An inhibitory and an excitatory factor of mammalian central nervous system, and their actions on a single sensory neuron. Arch Int Physiol 62:33–53
Foerster O (1911) Die Behandlung spastischer Lähmungen durch Resektion hinterer Rückenmarkswurzeln. Ergeb Chir 2:174–209
Fox S, Krnjević K, Morris ME, Puil E, Werman R (1978) Action of baclofen on mammalian synaptic transmission. Neuroscience 3:495–515
From A, Heltberg A (1975) A double-blind trial with baclofen and diazepam in spasticity due to multiple sclerosis. Acta Neurol Scand 51:158–166
Fromm GH, Terrence CF, Chattha AS, Glass JD (1980) Baclofen in trigeminal neuralgia. Its effect on the spinal trigeminal nucleus: a pilot study. Arch Neurol 37:768–771
Fung SC, Swarbrick MJ, Fillenz M (1985) Effect of baclofen on in vitro noradrenaline release from rat hippocampus and cerebellum: an action at an alpha2-adrenoceptor. Neurochem Int 7:155–163
Fukuda H, Kudo Y, Ono H (1977) Effects of β-(p-chlorphenyl-)GABA (baclofen) on spinal synaptic activity. Eur J Pharmacol 44:17–24
Gemer HJ, Rauda DW, Witterstätter K (1979) Die soziale Situation von Querschnittgelähmten. Eine empirische Untersuchung. Rehabilitation 18:135–149
Gerschenfeld HM (1973) Chemical transmission in invertebrate central nervous systems and neuromuscular junction. Physiol Rev 53:1–119
Ghose K, Holmes KM, Matthewson K (1980) Complications of baclofen overdosage. Postgrad Med J 56:865–867
Gillis RA, Yamada KA, Dimicco JA, Williford DJ, Segal SA, Hamosh P, Norman WP (1984) Central gamma-aminobutyric acid involvement in blood pressure control. Fed Proc 43:32–38
Gray JA, Metz A, Goodwin GM, Green AR (1986) The effect of GABA-mimetic drugs, progabide and baclofen, on the biochemistry and function of 5-hydroxytryptamine and noradrenaline. Neuropharmacology 25:711–716
Green AR (1986) Changes in GABA biochemistry and seizure threshold. Ann NY Acad Sci 462:105–119
Hammond DL, Drower EJ (1984) Effects of intrathecally administered THIP, baclofen and muscimol on nociceptive threshold. Eur J Pharmacol 103:121–125
Hassan N, McLellan DL (1980) Double-blind comparison of single doses of DS 103-282, baclofen and placebo for suppression of spasticity. J Neurol Neurosurg Psychiatry 43:1132–1136
Hassler R (1981) Neuronale Grundlagen der spastischen Tonussteigerung. In: Bauer HJ, Koella WP, Struppler A (eds) Therapie der Spastik. Verlag für angewandte Wissenschaften, München, pp 11–38
Hattab JR (1980) Review of European trials with baclofen. In: Feldman RG, Young RR, Koella WP (eds) Spasticity: disordered motor control. Symposia Specialists, Miami, pp 71–75
Hayashi T, Nagai K (1956) Action of amino acids on the motor cortex of higher animals, especially γ-amino-β oxybutyric acid as a real inhibitory principle in brain. Proc XX Int Physiol Congress:410
Head H, Riddoch G (1917) The automatic bladder, excessive sweating and some other reflex conditions in gross injuries of the spinal cord. Brain 40:188–263
Hedley DW, Maroun JA, Espir MLE (1975) Evaluation of baclofen for spasticity in multiple sclerosis. Postgrad Med J 51:615–622
Henry JL (1980) Pharmacologic studies on baclofen in the spinal cord of the cat. In: Feldman RG, Young RR, Koella WP (eds) Spasticity: disordered motor control. Year Book, Chicago, pp 437–452
Herman R (1970) The myotactic reflex: Clinico-physiological aspects of spasticity and contracture. Brain 99:237–312
Howe JR, Zieglgänsberger W (1986) D-Baclofen does not antagonize the actions of l-baclofen on rat neocortical neurons in vitro. Neurosci Lett 72:99–104
Hudgson P, Weightman D (1971) Baclofen in the treatment of spasticity. Br Med J 4:15–18
Hyser CL, Drake ME (1984) Status epilepticus after baclofen withdrawal. J Natl Med Assoc 76:533–538
Jensen D (1979) Spastiske nedre urinveier. Er det indisert med. In: Dietrichson P, Nyberg-Hansen R (eds) Spastisotet og rigiditet. Cyba-Geigy, Switzerland, pp 259–271
Johnston GAR, Hailstone MH, Freeman CG (1980) Baclofen: stereo-selective inhibition of excitant amino acid release. J Pharm Pharmacol 32:230–231
Jones RF, Burke D, Marosszeky JE, Gillies JD (1970) A new agent for the control of spasticity. J Neurol Neurosurg Psychiatry 33:464–468
Jones RF, Lance JW (1976) Baclofen in the long-term management of spasticity. Med J Aust 1:654–657
Kehoe JS, Marder E (1976) Identification and effects of neural transmitters in invertebrates. Annu Rev Pharmacol 16:245–268
Koella WP (1980) Baclofen: its general pharmacology and neuropharmacology. In: Feldman RG, Young GG, Koalla WP (eds) Spasticity: disordered motor control. Year Book, Chicago, pp 383–396
Krogsgaard-Larsen P, Scheel-Kruger J, Kofod H (1979) GABA-neurotransmitters. Academic Press, New York
Krnjevic K (1974) Chemical nature of synaptic transmission in vertebrates. Physiol Rev 54:418–540
Kurnick NB (1956) Autonomic hyperreflexia and its control in patients with spinal cord lesions. Ann Intern Med 44:678–686
Lalley PM (1980) Unexpected disinhibitory effects of baclofen on cardiovascular and respiratory neurons. Brain Res Bull 5:565–573
Lalley PM (1980) Inhibition of depressor cardiovascular reflexes by a derivate of gamma-aminobutyric acid (GABA) and by general anesthetics with suspected GABA-mimetic effects. J Pharmacol Exp Ther 215:418–425
Lalley PM (1983) Biphasic effects of baclofen on phrenic motoneurons: possible involvement of two types of gamma-aminobutyric acid (GABA) receptors. J Pharmacol Exp Ther 226:616–624
Lalley PM (1986) Effects of baclofen and gamma-aminobutyric acid on different types of medullary respiratory neurons. Brain Res 376:392–395
Lang HD, Dürr W, Hoffmann J, Koeth R (1980) Post-clinical follow-up of spinal patients through domestic check-ups. Paraplegia 18:140–144
Lanz E, Däubler F, Eissner D, Brod KH, Theiß D (1986) Der Einfluß der spinalen Liquordynamik auf die subarachnoidale Ausbreitung rückenmarksnah applizierter Substanzen. Reg Anaesth 9:4–8
Levine IM, Jossmann PB, DeAngelis V (1972) Quantitative Wirkungsbeurteilung von CIBA 34 647 Ba. Ein vorläufiger Bericht. In: Birkmayer W (ed) Aspekte der pp 50–70
Levy RA, Proudfit HK (1977) The analgesic action of baclofen. J Pharmacol Exp Ther 202:437–442
Lipscomb DJ, Meredith TJ (1980) Baclofen overdose. Postgrad Med J 56:108–109
Lloyd KG, Bartholini G, Morselli P (1986) GABA and mood disorders. Raven Press, New York
Lloyd KG, Pilc A (1984) Chronic antidepressants and GABA synapses. Neuropharmacology 23:841–842
Löscher W (1982) Comparative assay of anticonvulsant and toxic potencies of sixteen GABAmimetic drugs. Neuropharmacology 21:803–810
Lowitzsch K, D’Amato P, Krämer G (1981) Wirkung von Lioresal auf Kontraktion und isometrische Kraft der quergestreiften Muskulatur. In: Bauer HJ, Koella WP, Struppler A (eds) Therapie der Spastik. Verlag für angewandte Wissenschaften, München, pp 173–175
Martensson A, Knutsson E (1981) Effects of baclofen on different components in the disorganized motor control in spastic paresis. In: Bauer HJ, Koella WP, Struppler A (eds) Therapie der Spastik. Verlag für angewandte Wissenschaften, München, pp 193–199
Matthews PBC (1959) The dependence of tension upon extension in the stretch reflex of the soleus muscle in the decerebrate cat. J Physiol (Lond) 147:521–546
Matthews WB (1966) Ratio of maximum H reflex to maximum M response as a measure of spasticity. J Neurol Neurosurg Psychiatry 29:201–204
May CR (1983) Baclofen overdose. Ann Emerg Med 12:171–173
McDowell FH (1981) Treatment of spasticity. Drugs 22:401–408
McLellan DL, Selwyn M, Cooper IS (1978) Time course of clinical and physiological effects of stimulation of the cerebellar surface in patients with spasticity. J Neurol Neurosurg Psychiatry 41:150–160
Meldrum B (1984) GABAergic agents as anticonvulsants in baboons with photosensitive epilepsy. Neurosci Lett 47:345–349
Michel M (1983) Rehabilitationsverlauf nach Schädelhirntrauma bei Kindern — eine neurophysiologische Studie. Rehabilitation 22:137–148
Milhorat TH (1975) The third circulation revisited. J Neurosurg 42:628–635
Misgeld U, Klee MR, Zeise ML (1981) Baclofen blockiert die GABAerge Hemmung im Hippocampus. In: Bauer HJ, Koella WP, Struppler A (eds) Therapie der Spastik. Verlag für angewandte Wissenschaften, München, pp 111–114
Morselli P, Lloyd KG (1986) Epilepsy and GABA receptor agonists: Basic and clinical research. Raven Press, New York
Müller H, Vogelberger W, Aigner K, Herget HF, Hempelmann G (1983) Kontinuierliche peridurale Opiatapplikation mit einer implantierten Pumpe. Implantationstechnik und erste Ergebnisse. Reg Anaesth (Anaesthesist) 6:47–51
Neuhäuser G (1975) Methods of assessing and recording motor skills and movement patterns. Dev Med Child Neurol 17:369–386
Noth J, Friedemann HH (1984) Die Analyse langlatenziger Dehnungsreflexe zur Erkennung spastischer Syndrome. In: Conrad B, Benecke R, Bauer HJ (eds) Die klinische Wertung der Spastizität. Schattauer, Stuttgart, New York, pp 113–121
Olpe HR, Baudry M, Fagni L, Lynch G (1982) The blocking action of baclofen on excitatory transmission in the rat hippocampal slice. J Neurosci 2:698–703
Olpe HR, Demiéville H, Baltzer H, Bencze WL, Koella WP, Wolf P, Haas HL (1978) The biological activity of d-and l-baclofen. Eur J Pharmacol 52:133–136
Olsen PZ, Diamantopoulos E (1967) Excitability of spinal motor neurones in normal subjects and patients with spasticity, Parkinsonian rigidity and cerebellar hypotonia. J Neurol Neurosurg Psychiatry 30:325–331
Otsuka M, Yanagisawa M (1980) The effect of substance P and baclofen on motorneurons of isolated spinal cord of the newborn rat. J Exp Biol 89:201–214
Panerai AE, Massei R, De Silva E, Sacerdote P, Monza G, Mantegazza P (1985) Baclofen prolongs the analgesic effect of fentanyl in man. Br J Anaesth 57:954–955
Paulson GW (1976) Overdose of Lioresal. Neurology 26:1105–1106
Pedersen E, Arlien-Soborg P, Grynderup V (1970) GABA derivate in spasticity. Acta Neurol Scand 46:257–266
Pedersen A, Arlien-Soborg P, Mai P (1974) The mode of action of the GABA derivate baclofen in human spasticity. Acta Neurol Scand 50:665–680
Penn RD, Paice JA, Gottschalk W, Ivankovich AD (1984) Cancer pain relief using chronic morphine infusion. Early experience with a programmable implanted drug pump. J Neurosurg 61:302–306
Persson B, Henning M (1980) Central cardiovascular and biochemical effects of baclofen in the conscious rat. J Pharm Pharmacol 32:417–422
Piercy M, Hollister RP (1979) Effects of intravenous baclofen on dorsal horn neurons in spinal cat. Eur J Pharmacol 53:379–382
Pinto ODS, Polikar M, Debono G (1972) Results of international clinical trials with Lioresal. Postgrad Med J 48:18–23
Polacek L, Schuppien W (1972) Vier Jahre in der Behandlung der multiplen Sklerose mit Lioresal. In: Birkmayer W (ed) Aspekte der Muskelspastik. Huber, Bern Stuttgart Wien, pp 123–127
Potashner SJ (1978) Baclofen: effects on aminoacid release. Can J Physiol Pharmacol 56:150–156
Prosiegel M, Neu I, Pfaffenrath V, Nahme M (1982) Thrombozytenaggregation und Multiple Sklerose. Nervenarzt 53:227–230
Roberts E, Chase TN, Tower DB (1976) GABA in nervous system function. Raven Press, New York
Roberts E, Frankel S (1950) γ-aminobutyric acid in the brain. Fed Proc 9:219
Sachais BA, Logue JN, Carey MS (1977) Baclofen, a new antispastic drug. Arch Neurol 34:422–428
Saito K, Konishi S, Otsuko M (1975) Antagonism between Lioresal and substance P in the rat spinal cord. Brain Res 97:177–182
Sawa GM, Paty DW (1979) The use of baclofen in treatment of spasticity in multiple sclerosis. Can J Neurol Sci 6:351–356
Sawynok J (1986) Baclofen activates two distinct receptors in the rat spinal cord and guinea pig ileum. Neuropharmacology 25: 795–798
Sawynok J, Dickson C (1984) D-Baclofen: Is it an antagonist at baclofen receptors? Prog Neuropsychopharmacol Biol Psychiatry 8:729–731
Sawynok J, Dickson C (1985) D-Baclofen is an antagonist at Baclofen receptors mediating antinociception in the spinal cord. Pharmacology 31:248–259
Sawynok J, Dickson C (1985) Evidence for the involvement of descending noradrenergic pathways in the antinociceptive effect of baclofen. Brain Res 335:89–97
Sawynok J, Reid A (1986) Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain. Neurochem Res 11:723–731
Schepelmann F (1974) Dissociation of motoricity in cerebral lesions. In: Umbach W, Koepchen P (eds) Central-rhythmic and regulation. Hippokrates, Stuttgart, pp 295–301
Schepelmann F (1975) The treatment of spasticity by Foerster’s operation. In: Klug W, Brock M, Klinger M, Spoerri O (eds) Meningiomas-Multiple sclerosis-Forensic problems in neurosurgery. Springer, Berlin Heidelberg New York, pp 417–419
Schepelmann F (1979) Rhythmic patterns of motor activity after lesions of the central nervous system in man. Acta Neurochir (Wien) 49:153–189
Schepelmann F (1976) Human motor activity in decerebrate states and their sequelae. Acta Neurochir (Wien) 46:185–217
Seyfert S, Straschill M (1982) Elektroenzephalographische Veränderungen unter Baclofen. Z Elektroenzeph Elektromyogr 13:161–166
Sill JC, Schumacher K, Southorn K, Reuter J, Yaksh TL (1986) Bradycardia and hypotension associated with baclofen used during general anesthesia. Anesthesiology 64:255–258
Sindou M, Millet MF, Moretiemais J, Eysette M (1981) Results of selective posterior rhizotomy in the treatment of painful and spastic paraplegia secondary to multiple sclerosis. Appl Neurophysiol 45:335–340
Smith DF (1984) Stereoselectivity of spinal neurotransmission: effects of baclofen enantiomer on tail-flick reflex in rats. J Neural Transm 60:63–67
Smolenski C, Muff S, Smolenski-Kautz S (1981) A double-blind comparative trial of a new muscle relaxant, tizanidine (DS 103-284) and baclofen in the treatment of chronic spasticity in multiple sclerosis. Curr Med Res Opin 7:374–383
Steardo L, Leo A, Marano E (1984) Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. Eur Neurol 23:51–55
Struppler A (1981) Klinik und Physiologie der Spastik. In: Bauer HJ, Koella WP, Struppler A (eds) Therapie der Spastik. Verlag für angewandte Wissenschaften, München, pp 115–124
Swartzwelder HS, Bragdon AC, Sutch CP, Ault B, Wilson WA (1986) Baclofen suppresses hippocampal epileptiform activity at low concentrations without suppressing synaptic transmission. J Pharmacol Exp Ther 237:881–887
Terrence CF, Fromm GH (1981) Complications of baclofen withdrawal. Arch Neurol 38:588–589
Terrence CF, Fromm GH, Roussan MS (1983) Baclofen: Its effect on seizure frequency. Arch Neurol 40:28–29
Warren SA, Warren KG (1981) Multiple sclerosis and related diseases: a relationship to diabetes mellitus. Can J Neurol Sci 8:35–39
Wesendanger M (1967) Morphological, electrophysiological and pathological aspects of interneurones: In: Widén L (ed) Recent advances in clinical neurophysiology. Elsevier, Amsterdam, pp 47–58
Williford DJ, DiMicco JA, Gillis RA (1980) Evidence for the presence of a tonically active forebrain GABAsystem influencing central sympathetic outflow in the cat. Neuropharmacology 19:245–250
Wilson PR, Yaksh TL (1978) Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 51:323–330
Yaksh TL, Müller H (1982) Spinal opiate analgesia. Experimental and clinical studies. Springer, Berlin Heidelberg New York
Yaksh TL, Reddy SV (1981) Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alphaadrenergic agonists and baclofen. Anesthesiology 54:451–467
Yamada KA, Norman WP, Hamosh P, Gillis RA (1982) Medullary ventral surface GABA receptors affect respiratory and cardiovascular function. Brain Res 248:71–78
Young RR, Delwaide PJ (1981) Drug therapy: spasticity. N Engl J Med 304:96–99
Zander KJ, Puerner K, Struppler A (1981) Motorische Kontrollmechanismen beim hemispastischen Syndrom. Effekte von Baclofen. In: Bauer HJ, Koella WP, Struppler A (eds) Therapie der Spastik. Verlag für angewandte Wissenschaften, München, pp 149–162
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Müller, H., Zierski, J., Dralle, D., Hoffmann, O., Michaelis, G. (1988). Intrathecal Baclofen in Spasticity. In: Müller, H., Zierski, J., Penn, R.D. (eds) Local-spinal Therapy of Spasticity. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72954-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-72954-6_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18295-5
Online ISBN: 978-3-642-72954-6
eBook Packages: Springer Book Archive